Evidence map›Paper›PMID 35602077›Full record

ArticleFrontiers in microbiology2022

Role of ABO Blood Group in SARS-CoV-2 Infection in Households.

Ales Janda, Corinna Engel, Jonathan Remppis, Sigrid Enkel, Andreas Peter, Sebastian Hörber, Tina Ganzenmueller, Sarah Schober, Christof Weinstock, Eva-Maria Jacobsen and 14 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 8 institutions in 1 country.

Ales JandaDepartment of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm University, Ulm, Germany.
Corinna EngelCenter for Pediatric Clinical Studies, University Children's Hospital Tübingen, Tübingen, Germany.
Jonathan RemppisUniversity Children's Hospital Tübingen, Tübingen, Germany.
Sigrid EnkelCenter for Clinical Transfusion Medicine Tübingen, Tübingen, Germany.
Andreas PeterInstitute for Clinical Chemistry and Pathobiochemistry, University Hospital Tübingen, Tübingen, Germany.
Sebastian HörberInstitute for Clinical Chemistry and Pathobiochemistry, University Hospital Tübingen, Tübingen, Germany.
Tina GanzenmuellerInstitute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen, Tübingen, Germany.
Sarah SchoberUniversity Children's Hospital Tübingen, Tübingen, Germany.
Christof WeinstockDepartment of Transfusion Medicine, Ulm University, Ulm, Germany.
Eva-Maria JacobsenDepartment of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm University, Ulm, Germany.
Dorit FabriciusDepartment of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm University, Ulm, Germany.
Maria ZernickelDepartment of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm University, Ulm, Germany.
Thomas StammingerInstitute of Virology, Ulm University Medical Center, Ulm, Germany.
Andrea DietzInstitute of Virology, Ulm University Medical Center, Ulm, Germany.
Hans-Jürgen GroßInstitute of Clinical Chemistry, Ulm University Medical Center, Ulm, Germany.
Sebastian F N BodeDepartment of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm University, Ulm, Germany.
Anneke D M HaddadCenter for Pediatrics and Adolescent Medicine, Medical Center Freiburg, Germany and Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Roland EllingCenter for Pediatrics and Adolescent Medicine, Medical Center Freiburg, Germany and Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Maximilian StichDepartment of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.
Burkhard TönshoffDepartment of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.
Philipp HennekeCenter for Pediatrics and Adolescent Medicine, Medical Center Freiburg, Germany and Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Klaus-Michael DebatinDepartment of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm University, Ulm, Germany.
Axel R FranzCenter for Pediatric Clinical Studies, University Children's Hospital Tübingen, Tübingen, Germany.
Hanna RenkUniversity Children's Hospital Tübingen, Tübingen, Germany.
Universität Ulm · DEUniversity Children's Hospital Tübingen · DEUniversity Hospital Heidelberg · DEUniversity of Freiburg · DEUniversity of Tübingen · DEBernstein Center for Computational Neuroscience Tübingen · DEInstitute of Medical Microbiology and Hygiene · DEUniversity Medical Center Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An association between certain ABO/Rh blood groups and susceptibility to SARS-CoV-2 infection has been proposed for adults, although this remains controversial. In children and adolescents, the relationship is unclear due to a lack of robust data. Here, we investigated the association of ABO/Rh blood groups and SARS-CoV-2 in a multi-center study comprising 163 households with 281 children and 355 adults and at least one SARS-CoV-2 seropositive individual as determined by three independent assays as a proxy for previous infection. In line with previous findings, we found a higher frequency of blood group A (+ 6%) and a lower frequency of blood group O (-6%) among the SARS-CoV-2 seropositive adults compared to the seronegative ones. This trend was not seen in children. In contrast, SARS-CoV-2 seropositive children had a significantly lower frequency of Rh-positive blood groups. ABO compatibility did not seem to play a role in SARS-CoV-2 transmission within the families. A correction for family clusters was performed and estimated fixed effects of the blood group on the risk of SARS-CoV-2 seropositivity and symptomatic infection were determined. Although we found a different distribution of blood groups in seropositive individuals compared to the reference population, the risk of SARS-CoV-2 seropositivity or symptomatic infection was not increased in children or in adults with blood group A or AB versus O or B. Increasing age was the only parameter positively correlating with the risk of SARS-CoV-2 infection. In conclusion, specific ABO/Rh blood groups and ABO compatibility appear not to predispose for SARS-CoV-2 susceptibility in children.

Indexed as

ABO blood groupchildrenCOVID-19household transmissionSARS-CoV-2

Identifiers

PMID35602077
PMCPMC9120758
OpenAlexW4229081765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.